Dr. Scholl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Cambridge SOM
Ridgefield, CT 06877
Education & Training
University of Cambridge School of MedicineClass of 1981
Certifications & Licensure
CT State Medical License 2002 - 2018
Publications & Presentations
PubMed
- 3 citationsClinical profile of the functionally selective glucocorticoid receptor agonist BI 653048 in healthy male subjectsChristian Harcken, Paul Scholl, Gerald Nabozny, David S. Thomson, Daniel Bianchi
Expert Opinion on Investigational Drugs. 2019-04-09 - 257 citationsRisankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen
Annals of the Rheumatic Diseases. 2018-06-26 - 20 citationsOnline monitoring of biotransformations in high viscous multiphase systems by means of FT-IR and chemometrics.Jakob Müller, Markus Neumann, Paul Scholl, Lutz Hilterhaus, Marrit Eckstein
Analytical Chemistry. 2010-06-16
Press Mentions
Helmsley Awards $4.7 Million for Crohn's Diet Therapy ResearchNovember 25th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
